James E. Dentzer
CIK: 0001400977
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jul 31, 2026IMNN
Imunon, Inc.
Award(A)Direct6.9K shares at avg. $1.59$11K - Jul 7, 2026CRIS
CURIS INC
Award(A)DirectEmployee stock option (right to buy)
110.1K shares at avg. $5.29- - May 22, 2026IMNN
Imunon, Inc.
Award(A)Direct11.1K shares at avg. $2.20$25K - Mar 20, 2026CRIS
CURIS INC
Conversion(C)Direct133.3K shares- - Mar 17, 2026CRIS
CURIS INC
Award(A)DirectSeries B Warrant (right to buy)
133.3K shares- - Mar 17, 2026CRIS
CURIS INC
Award(A)DirectSeries A Warrant (right to buy)
133.3K shares- - Mar 17, 2026CRIS
CURIS INC
Award(A)DirectSeries C Warrant (right to buy)
133.3K shares- - Mar 17, 2026CRIS
CURIS INC
Award(A)DirectSeries B Convertible Preferred Stock
100 shares- - Jan 2, 2026IMNN
Imunon, Inc.
Award(A)DirectStock Option (Right to Buy)
4.4K shares- - Aug 4, 2025IMNN
Imunon, Inc.
Award(A)Direct3.3K shares at avg. $9.20$31K - May 20, 2025CRIS
CURIS INC
Award(A)DirectEmployee stock option (right to buy)
360K shares at avg. $3.13- - Mar 14, 2025IMNN
Imunon, Inc.
Award(A)DirectStock Option (Right to Buy)
3.8K shares- - Jan 28, 2025CRIS
CURIS INC
Award(A)DirectEmployee stock option (right to buy)
40K shares at avg. $3.13- - Sep 6, 2024IMNN
Imunon, Inc.
Award(A)DirectStock Option (Right to Buy)
3.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 | IMNN Imunon, Inc. | Award(A) | 6,934 | $1.59 | $11,025 | Direct |
| Jul 7, 2026 | CRIS CURIS INC | Award(A) Employee stock option (right to buy) | 110,090 | $5.29 | - | Direct |
| May 22, 2026 | IMNN Imunon, Inc. | Award(A) | 11,148 | $2.20 | $24,526 | Direct |
| Mar 20, 2026 | CRIS CURIS INC | Conversion(C) | 133,333 | - | $0 | Direct |
| Mar 17, 2026 | CRIS CURIS INC | Award(A) Series B Warrant (right to buy) | 133,333 | - | - | Direct |
| Mar 17, 2026 | CRIS CURIS INC | Award(A) Series A Warrant (right to buy) | 133,333 | - | - | Direct |
| Mar 17, 2026 | CRIS CURIS INC | Award(A) Series C Warrant (right to buy) | 133,333 | - | - | Direct |
| Mar 17, 2026 | CRIS CURIS INC | Award(A) Series B Convertible Preferred Stock | 100 | - | - | Direct |
| Jan 2, 2026 | IMNN Imunon, Inc. | Award(A) Stock Option (Right to Buy) | 4,405 | - | - | Direct |
| Aug 4, 2025 | IMNN Imunon, Inc. | Award(A) | 3,318 | $9.20 | $30,526 | Direct |
| May 20, 2025 | CRIS CURIS INC | Award(A) Employee stock option (right to buy) | 360,000 | $3.13 | - | Direct |
| Mar 14, 2025 | IMNN Imunon, Inc. | Award(A) Stock Option (Right to Buy) | 3,750 | - | - | Direct |
| Jan 28, 2025 | CRIS CURIS INC | Award(A) Employee stock option (right to buy) | 40,000 | $3.13 | - | Direct |
| Sep 6, 2024 | IMNN Imunon, Inc. | Award(A) Stock Option (Right to Buy) | 3,634 | - | - | Direct |
1-14 of 14 transactions
About Dentzer James E
Dentzer James E (SEC CIK 0001400977) files insider reports with the SEC as Director of Imunon, Inc. (IMNN) and President & CEO of CURIS INC (CRIS).
Signal8 holds 11 ownership filings by Dentzer James E, all Form 4s, filed between Sep 10, 2024 and Aug 4, 2026. Those filings report 14 transactions, from Sep 6, 2024 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dentzer James E's filings is in LAWRENCEVILLE, NJ.
Recent filings by Dentzer James E
- Jul 31, 2026: Grant or award of IMNN shares (Form 4, code A).
- Jul 7, 2026: Grant or award of CRIS derivative securities (Form 4, code A).
- May 22, 2026: Grant or award of IMNN shares (Form 4, code A).
- Mar 20, 2026: Conversion of CRIS shares (Form 4, code C).
- Mar 17, 2026: Grants or awards of CRIS derivative securities (4 lines, Form 4, code A).
Other insiders filing for Imunon, Inc. (IMNN)
- Tardugno Michael H, Executive Chairman of Board
- Lindborg Stacy, President and CEO
- Faller Douglas Vincent, Chief Medical Officer
- Eylward Susan, General Counsel and Corp Sec
- Pellizzari Christine A, Director
- Fritz Frederick J., Director